1. Home
  2. ASTI vs BDRX Comparison

ASTI vs BDRX Comparison

Compare ASTI & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascent Solar Technologies Inc.

ASTI

Ascent Solar Technologies Inc.

HOLD

Current Price

$4.57

Market Cap

34.3M

Sector

Technology

ML Signal

HOLD

Logo Biodexa Pharmaceuticals plc

BDRX

Biodexa Pharmaceuticals plc

HOLD

Current Price

$3.10

Market Cap

1.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTI
BDRX
Founded
2005
2000
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.3M
1.8M
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
ASTI
BDRX
Price
$4.57
$3.10
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$20.00
N/A
AVG Volume (30 Days)
1.7M
5.5M
Earning Date
05-11-2026
09-12-2025
Dividend Yield
N/A
N/A
EPS Growth
70.23
N/A
EPS
N/A
N/A
Revenue
$10,398,149.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
163.25
N/A
52 Week Low
$1.40
$0.60
52 Week High
$9.87
$11.88

Technical Indicators

Market Signals
Indicator
ASTI
BDRX
Relative Strength Index (RSI) 48.77 54.24
Support Level $3.50 $2.86
Resistance Level $4.68 $4.39
Average True Range (ATR) 0.83 0.28
MACD -0.03 -0.13
Stochastic Oscillator 26.91 3.52

Price Performance

Historical Comparison
ASTI
BDRX

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is a solar technology company that manufactures and sells photovoltaic (PV) solar modules that are flexible, durable, and possess attractive power to weight and power to area performance. Its technology provides renewable power solutions to high-value production and specialty solar markets where traditional rigid solar panels are not suitable, including space power beaming, aerospace, satellites, near earth orbiting vehicles, fixed wing unmanned aerial vehicles (UAV), aquatic, terrestrial, and other weight-sensitive markets with transformational high quality, value added product applications. It operates in single PV segment that sells PV products and engineering services and currently, is selling it in North America.

About BDRX Biodexa Pharmaceuticals plc

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Share on Social Networks: